About ZMYND11 Treatment Foundation

A ZMYND11 gene disorder is very rare, yet rapidly growing with an estimated 200 individuals worldwide with a pathogenic or likely pathogenic gene mutation. This number is growing with more genetic testing and awareness. Our goal is to find treatments that improve the function of the ZMYND11 protein, to decrease the severity of symptoms caused by the disorder.

In 2026, with the help of your donations, the Foundation began the first drug repurposing screen for pathogenic ZMYND11 variants.

Continued fundraising beyond our current goal minimizes barriers to treatment for all those affected by supporting observational studies, establishing a diagnostic code, and obtain FDA approval of treatments for use specifically for ZMYND11 gene disorders.

We created this campaign to offer the opportunity to be part of treatment discovery. Be sure to review the ways you can make an impact and share this page with your family and friends. Follow our #zmynd11 progress on Facebook or Instagram @ZMYND11_Treatment_Foundation.
More information can be found at zmynd11.org.